Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Sell
2,665
-1,039
-28% -$122K 0.17% 73
2026
Q1
$332K Buy
3,704
+959
+35% +$111K 0.21% 67
2025
Q4
$289K Hold
2,745
0.16% 70
2025
Q3
$230K Buy
+2,745
New +$226K 0.13% 75
2022
Q3
$300K Hold
3,480
0.25% 64
2022
Q2
$317K Sell
3,480
-306
-8% -$27.1K 0.25% 63
2022
Q1
$311K Hold
3,786
0.2% 68
2021
Q4
$290K Sell
3,786
-850
-18% -$67.7K 0.18% 69
2021
Q3
$348K Sell
4,636
-11,875
-72% -$903K 0.22% 65
2021
Q2
$1.28M Buy
+16,511
New +$1.23M 0.81% 36

Other funds holding MRK

Corsicana & Co's MRK Position: Q2 2026 in Review

Corsicana & Co reduced its Merck (MRK) stake by 28% in Q2 2026, selling an estimated $122K and leaving 2,665 shares worth $342K. The position accounts for 0.17% of the portfolio, ranked #73.

Corsicana & Co first reported a position in MRK in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.28M in Q2 2021. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Corsicana & Co held 2,665 shares of Merck worth $342K as of Q2 2026.
  • Corsicana & Co sold 1,039 Merck shares in Q2 2026, an estimated $122K.
  • Merck made up 0.17% of Corsicana & Co's portfolio in Q2 2026, its #73 holding.
  • Corsicana & Co first reported a position in Merck in Q2 2021 and has held it in 10 quarters since.
  • Corsicana & Co's Merck position peaked at $1.28M in Q2 2021.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.